Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Is the stereoisomer R-MDMA a safer version of MDMA?
    Published on 2024-10-24
    2 years ago
  • Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy
    Published on 2024-10-23
    2 years ago
  • Deep phenotyping reveals CRH and FKBP51-dependent behavioral profiles following chronic social stress exposure in male mice
    Published on 2024-10-22
    2 years ago
  • NPP Editorial: tides of progress
    Published on 2024-10-22
    2 years ago
  • Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
    Published on 2024-10-21
    2 years ago
  • Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study
    Published on 2024-10-16
    2 years ago
  • PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
    Published on 2024-10-16
    2 years ago
« Previous 1 … 70 71 72 73 74 … 143 Next »
Journal of Psychopharmacology
  • Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
    Published on 2023-01-05
    4 years ago
  • Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective
    Published on 2023-01-02
    4 years ago
  • A unified model of ketamine’s dissociative and psychedelic properties
    Published on 2022-12-17
    4 years ago
  • Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder
    Published on 2022-12-14
    4 years ago
  • Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults
    Published on 2022-12-14
    4 years ago
  • Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
    Published on 2022-12-14
    4 years ago
  • Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial
    Published on 2022-12-14
    4 years ago
« Previous 1 … 70 71 72 73 74 … 150 Next »
European Neuropsychopharmacology
  • Defining cannabis risky use: Building the plane while you fly it
    Published on 2023-02-18
    3 years ago
  • Premise, promise and challenges of MDMA assisted therapy for PTSD
    Published on 2023-02-16
    3 years ago
  • Robotics in psychiatry – Fiction or reality?
    Published on 2023-02-16
    3 years ago
  • Improving drug development in precision psychiatry by ameliorating cognitive biases
    Published on 2023-02-15
    3 years ago
  • A shared decision journey to bridge the gap between treatment recommendation and low adherence?
    Published on 2023-02-13
    3 years ago
  • Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
    Published on 2023-02-13
    3 years ago
  • Treating major depressive disorder with mixed features
    Published on 2023-02-13
    3 years ago
« Previous 1 … 70 71 72 73 74 … 168 Next »

   Pharma Pub